Highlights
- 1Cancers · 2024
- 2
- 3Journal of thoracic disease · 2024
Publications
49 publications
Funding
1 grant
Active
1 grant- Co-IMCC CTIF 250906-01Evaluating Lymph Node T Cell "Clonal Replacement" in a Phase II Trial of Neoadjuvant SBRT plus Cemiplimab versus Chemotherapy plus Cemiplimab in Resectable NSCLCWCM Sandra and Edward Meyer Cancer Center · 2025–2026
Clinical research
1 study
Active
1 study- PICirculating tumor DNA as a biomarker to characterize early-stage, ground-glass predominant, EGFR mutant lung cancersWeill Medical College of Cornell University · OPEN TO ACCRUAL (as of 2025)